Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anemia in men with advanced prostate cancer: incidence, etiology, and treatment.

Literature DB >> 16985564

Anemia in men with advanced prostate cancer: incidence, etiology, and treatment.

Jeffrey G Nalesnik, Angela G Mysliwiec, Edith Canby-Hagino.

Abstract

Anemia associated with advanced prostate cancer is a common occurrence. This article reviews the incidence and examines the various causes of this condition, including androgen deprivation, nutritional decline, bone marrow infiltration, treatment-related toxicity, and the chronic inflammatory state. Treatment of anemia in men with advanced prostate cancer is also discussed. In patients with limited bone marrow reserve, blood transfusions may be the only effective treatment.

Entities: Disease Species

Year: 2004 PMID： 16985564 PMCID： PMC1472681

Source DB: PubMed Journal: Rev Urol ISSN： 1523-6161

13 in total

Review 1. Complications of advanced prostate cancer.

Authors: J A Smith; M S Soloway; M J Young
Journal: Urology Date: 1999-12 Impact factor: 2.649

2. Development of anemia and recovery in prostate cancer patients treated with combined androgen blockade and radiotherapy.

Authors: S O Asbell; S A Leon; W J Tester; H D Brereton; C T Ago; M Rotman
Journal: Prostate Date: 1996-10 Impact factor: 4.104

Review 3. Recombinant human erythropoietin and the anemia of cancer.

Authors: J L Spivak
Journal: Blood Date: 1994-08-15 Impact factor: 22.113

Review 4. Supportive care, pain management, and quality of life in advanced prostate cancer.

Authors: P Esper; B G Redman
Journal: Urol Clin North Am Date: 1999-05 Impact factor: 2.241

5. Low doses of oral dexamethasone for hormone-refractory prostate carcinoma.

Authors: K Nishimura; N Nonomura; Y Yasunaga; N Takaha; H Inoue; H Sugao; S Yamaguchi; O Ukimura; T Miki; A Okuyama
Journal: Cancer Date: 2000-12-15 Impact factor: 6.860

6. Anemia associated with advanced prostatic adenocarcinoma: effects of recombinant human erythropoietin.

Authors: S Beshara; H Letocha; T Linde; B Wikström; B Sandhagen; S Nilsson; B G Danielson
Journal: Prostate Date: 1997-05-15 Impact factor: 4.104

7. Efficacy of epoetin beta on hemoglobin, quality of life, and transfusion needs in patients with anemia due to hormone-refractory prostate cancer--a randomized study.

Authors: J E Johansson; P Wersäll; Y Brandberg; S O Andersson; L Nordström
Journal: Scand J Urol Nephrol Date: 2001-09

Review 8. Erythropoietin in urologic oncology.

Authors: P Albers; R Heicappell; H Schwaibold; J Wolff
Journal: Eur Urol Date: 2001-01 Impact factor: 20.096

9. Leukoerythroblastic anemia in metastatic prostate cancer. Clinical and prognostic significance in patients with hormone-refractory disease.

Authors: G J Shamdas; F R Ahmann; M B Matzner; J M Ritchie
Journal: Cancer Date: 1993-06-01 Impact factor: 6.860

10. Anemia after orchiectomy.

Authors: R Fonseca; S V Rajkumar; W L White; A Tefferi; H C Hoagland
Journal: Am J Hematol Date: 1998-11 Impact factor: 10.047

10 in total

1. Analysis of the risk factors for myelosuppression after concurrent chemoradiotherapy for patients with advanced non-small cell lung cancer.

Authors: Nan Jiang; Xiao-Cen Chen; Yue Zhao
Journal: Support Care Cancer Date: 2012-08-31 Impact factor: 3.603

2. Predictors of hemoglobin decline in non-metastatic prostate cancer patients on androgen deprivation therapy: a matched cohort study.

Authors: Narhari Timilshina; Shabbir Hussain; Henriette Breunis; Shabbir M H Alibhai
Journal: Support Care Cancer Date: 2010-10-16 Impact factor: 3.603

3. Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases.

Authors: Carsten Nieder; Ellinor Haukland; Adam Pawinski; Astrid Dalhaug
Journal: BMC Cancer Date: 2010-06-13 Impact factor: 4.430

4. Network meta-analysis of the efficacy and adverse effects of several treatments for advanced/metastatic prostate cancer.

Authors: Jing Wu; Wei-Kang Chen; Wei Zhang; Jin-Song Zhang; Jian-He Liu; Yong-Ming Jiang; Ke-Wei Fang
Journal: Oncotarget Date: 2017-08-02

Review 5. Influence of Androgens on Immunity to Self and Foreign: Effects on Immunity and Cancer.

Authors: Isabel Ben-Batalla; María Elena Vargas-Delgado; Gunhild von Amsberg; Melanie Janning; Sonja Loges
Journal: Front Immunol Date: 2020-07-02 Impact factor: 7.561

6. Prevalence of anemia among Saudi patients with solid cancers at diagnosis in King Faisal Hospital, Taif Province, Kingdom of Saudi Arabia.

Authors: Mazen Almehmadi; Magdi Salih; Tariq E Elmissbah; Abdulaziz Alsharif; Naif Alsiwiehri; Khalid Alzahrani; Alaa Shafie; Haytham Dahlawi
Journal: PLoS One Date: 2021-01-28 Impact factor: 3.240

7. Impact of pretreatment anemia on upfront abiraterone acetate therapy for metastatic hormone-sensitive prostate cancer: a multicenter retrospective study.

Authors: Teppei Okamoto; Daisuke Noro; Shingo Hatakeyama; Shintaro Narita; Koji Mitsuzuka; Toshihiko Sakurai; Sadafumi Kawamura; Senji Hoshi; Jiro Shimoda; Toshikazu Tanaka; Toshiaki Kawaguchi; Shigeto Ishidoya; Akihiro Ito; Norihiko Tsuchiya; Tomonori Habuchi; Chikara Ohyama
Journal: BMC Cancer Date: 2021-05-25 Impact factor: 4.430